This man brings Synbiotic into the advisory board

As it prepares for cannabis legalization, the startup is getting prominent support from a cannabis multi-entrepreneur.

Synbiotic has appointed cannabis entrepreneur Bruce Linton to chair its newly created advisory board. The publicly traded company is looking to benefit from his industry knowledge as cannabis legalization approaches.

Linton is a well-known figure on the global cannabis scene: he is the founder and former chairman and chief executive officer of Canopy Growth Corporation. At the time of his departure, the cannabis company was reportedly worth about $20 billion Canadian and provided cannabis to more than 25 percent of the Canadian market. He also founded several other global cannabis companies listed on various exchanges including NYSE, Nasdaq, TSX, TSX:V, CSE and ASX.

"I see tremendous potential in the European market, especially with the recent announcement of legalization in Germany," says Bruce Linton. "I believe Synbiotic SE is ideally positioned to take full advantage of legalization and become the dominant cannabis company in Europe." Linton was also among the investors in the recent financing round and now holds about five percent of Synbiotic's shares. He is compensated for his work as an advisory board member depending on the development of the share price.